Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contacts | Login 
  Users Online: 280 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review

Haikal Ammar, Borba E, Khaja Taqui, Doolittle Gary, Schmidt Paul

Year : 2018| Volume: 8| Issue : 1 | Page no: 34-36

   This article has been cited by
1 EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
Marie Kostine,Axel Finckh,Clifton O Bingham,Karen Visser,Jan Leipe,Hendrik Schulze-Koops,Ernest H Choy,Karolina Benesova,Timothy R D J Radstake,Andrew P Cope,Olivier Lambotte,Jacques-Eric Gottenberg,Yves Allenbach,Marianne Visser,Cindy Rusthoven,Lone Thomasen,Shahin Jamal,Aurélien Marabelle,James Larkin,John B A G Haanen,Leonard H Calabrese,Xavier Mariette,Thierry Schaeverbeke
Annals of the Rheumatic Diseases. 2021; 80(1): 36
[Pubmed]  [Google Scholar] [DOI]
2 Cost-effectiveness of nivolumab in advanced melanoma: a drug review
Pol Specenier
Expert Review of Pharmacoeconomics & Outcomes Research. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
Yan Xiao,Lin Zeng,Qinglin Shen,Zhiyong Zhou,Zhifang Mao,Qin Wang,Xiquan Zhang,Yingliang Li,Weirong Yao
Journal of Immunology Research. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
4 An update on the safety of nivolumab for the treatment of advanced melanoma
Anna M Czarnecka,Piotr Rutkowski
Expert Opinion on Drug Safety. 2020; 19(4): 409
[Pubmed]  [Google Scholar] [DOI]
5 Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment
Susan Morand,Hannah Staats,Justin Fortune Creeden,Azwar Iqbal,Bashar Kahaleh,Laura Stanbery,Lance Dworkin,John Nemunaitis
Future Oncology. 2020;
[Pubmed]  [Google Scholar] [DOI]
6 Management of immune checkpoint inhibitor-related adverse events: A review of case reports
Xiaoyan Si,Peng Song,Jun Ni,Mingyi Di,Chunxia He,Li Zhang,Xiaowei Liu,Yue Li,Hanping Wang,Xiaoxiao Guo,Jiaxin Zhou,Lian Duan,Xu Yang,Mengzhao Wang,Li Zhang
Thoracic Cancer. 2020;
[Pubmed]  [Google Scholar] [DOI]
7 A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature
Bicky Thapa,Asad Ali,Raunak Nair,Rishik Vashisht,Cassandra Calabrese
Case Reports in Rheumatology. 2019; 2019: 1
[Pubmed]  [Google Scholar] [DOI]
8 Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient with Metastatic Gastric Adenocarcinoma
Masataka Nishikawa,Atsushi Goshima,Hajime Owaki,Takeshi Fuji
Clinical Drug Investigation. 2019;
[Pubmed]  [Google Scholar] [DOI]


Read this article